S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
OTCMKTS:CRPOF

Ceapro - CRPOF Stock Forecast, Price & News

$0.47
0.00 (0.00%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.46
$0.47
50-Day Range
$0.47
$0.54
52-Week Range
$0.36
$0.61
Volume
2,500 shs
Average Volume
13,726 shs
Market Capitalization
$36.78 million
P/E Ratio
7.64
Dividend Yield
N/A
Price Target
N/A

CRPOF stock logo

About Ceapro (OTCMKTS:CRPOF) Stock

Ceapro, Inc. engages in the development and marketing of natural products for personal care, cosmetic, human, and animal health industries. It operates through the Active Ingredient Product Technology Industry, and Cosmeceutical Industry segments. The Active Ingredient Product Technology Industry segment involves the development of proprietary extraction technologies and the application of these technologies to the production and development and commercialization of active ingredients derived from oats and other renewable plant resources for healthcare and cosmetic industries. The Cosmeceutical Industry segment develops and commercializes anti-aging products derived from natural active ingredients. The company was founded on May 12, 1987 and is headquartered in Edmonton, Canada.

Receive CRPOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ceapro and its competitors with MarketBeat's FREE daily newsletter.

CRPOF Stock News Headlines

Adam Mesh: “This Strategy Saved My Trading Career”
Adam Mesh was $50,000 in the hole - and ready to quit trading for good… Until he discovered the secret to unlocking double-digit income. This strategy has averaged 64% average gains in the last three years. Adam is hosting a free session to show ordinary folks how to execute this incredible strategy. Click here to let Adam show you how it’s done. pixel
Sell every Stock except ONE
Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...
Ceapro Lone Stock at 52-Week High
Global Electric Vehicle Outlook 2021
Ceapro reports Q4 results
Is It Time To Consider Buying Ceapro Inc. (CVE:CZO)?
Ceapro Inc. to Present at NobleCon17
See More Headlines
Receive CRPOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ceapro and its competitors with MarketBeat's FREE daily newsletter.

CRPOF Company Calendar

Today
3/31/2023
Next Earnings (Estimated)
4/11/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CRPOF
CIK
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$2.27 million
Pretax Margin
33.89%

Debt

Sales & Book Value

Annual Sales
$13.72 million
Cash Flow
$0.05 per share
Book Value
$0.28 per share

Miscellaneous

Free Float
N/A
Market Cap
$36.78 million
Optionable
Not Optionable
Beta
1.64

Key Executives

  • Gilles R. Gagnon
    President, Chief Executive Officer & Director
  • Stacy Prefontaine
    Chief Financial Officer & Secretary
  • Bernhard Seifried
    Senior Director-Research & Technology
  • Paul Moquin
    Director-Scientific Affairs & Business Development
  • Leoni DeJoya
    Vice President-Bioprocessing Business Unit













CRPOF Stock - Frequently Asked Questions

How have CRPOF shares performed in 2023?

Ceapro's stock was trading at $0.4810 at the beginning of the year. Since then, CRPOF shares have decreased by 2.3% and is now trading at $0.47.
View the best growth stocks for 2023 here
.

Are investors shorting Ceapro?

Ceapro saw a drop in short interest in March. As of March 15th, there was short interest totaling 1,700 shares, a drop of 46.9% from the February 28th total of 3,200 shares. Based on an average daily volume of 14,700 shares, the short-interest ratio is presently 0.1 days.
View Ceapro's Short Interest
.

When is Ceapro's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 11th 2023.
View our CRPOF earnings forecast
.

What is Ceapro's stock symbol?

Ceapro trades on the OTCMKTS under the ticker symbol "CRPOF."

How do I buy shares of Ceapro?

Shares of CRPOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ceapro's stock price today?

One share of CRPOF stock can currently be purchased for approximately $0.47.

How much money does Ceapro make?

Ceapro (OTCMKTS:CRPOF) has a market capitalization of $36.78 million and generates $13.72 million in revenue each year. The company earns $2.27 million in net income (profit) each year or $0.06 on an earnings per share basis.

How can I contact Ceapro?

Ceapro's mailing address is 7824 51 Avenue NW, Edmonton A0, T6E 6W2. The official website for the company is www.ceapro.com. The company can be reached via phone at (780) 421-4555, via email at czo@jtcir.com, or via fax at 780-421-1320.

This page (OTCMKTS:CRPOF) was last updated on 3/31/2023 by MarketBeat.com Staff